Despite a Food and Drug Administration (FDA) warning that giving young blood to older people might have adverse effects, blood infusion startup Ambrosia has reopened for business.
The Ambrosia Medical company sells blood plasma from donors aged 16-25 by the liter, claiming anti-aging benefits. They ceased offering the controversial treatment in February after the FDA issued a warning, that they have “significant public health concerns” about the practice.
